NCT03940469View on ClinicalTrials.gov

Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Interscalene Block

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 3, 2016

Primary Completion Date

January 1, 2019

Study Completion Date

January 1, 2019

Conditions
Postoperative AnalgesiaPostoperative Complications
Interventions
DRUG

Saline

2 ml normal saline

DRUG

Dexamethasone Injection

8 mg dexamethasone

DRUG

Dexmedetomidine Hydrochloride

100 microgram dexmedetomidine

Trial Locations (1)

1234

Ashraf Eskandr, Shibīn al Kawm

All Listed Sponsors
collaborator

Mamdoh Elsayed Lotfy

UNKNOWN

collaborator

Osama Abdallah Elsharkawy

UNKNOWN

collaborator

Basma Abdelhamid Fathy

UNKNOWN

lead

Menoufia University

OTHER

NCT03940469 - Dexmedetomidine Versus Dexamethasone With Levobupivacaine in Interscalene Block | Biotech Hunter | Biotech Hunter